Preserflo MicroShunt implantation appears to be an effective and well-tolerated method of reducing intraocular pressure in patients with secondary glaucoma following keratoplasty. Long-term follow-up in a larger patient cohort is needed to confirm these results.
Bolek et al. (Thu,) studied this question.